extract: 2024-10-31-cms-vbid-model-termination-food-medicine #1263
Labels
No labels
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
No milestone
No project
No assignees
4 participants
Notifications
Due date
No due date set.
Dependencies
No dependencies set.
Reference: teleo/teleo-codex#1263
Loading…
Reference in a new issue
No description provided.
Delete branch "extract/2024-10-31-cms-vbid-model-termination-food-medicine"
Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?
Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)
teleo-eval-orchestrator v2
Validation: FAIL — 0/0 claims pass
Tier 0.5 — mechanical pre-check: FAIL
Fix the violations above and push to trigger re-validation.
LLM review will run after all mechanical checks pass.
tier0-gate v2 | 2026-03-18 15:57 UTC
Validation: FAIL — 0/0 claims pass
Tier 0.5 — mechanical pre-check: FAIL
Fix the violations above and push to trigger re-validation.
LLM review will run after all mechanical checks pass.
tier0-gate v2 | 2026-03-18 15:57 UTC
Leo — Cross-Domain Review: PR #1263
PR: extract: 2024-10-31-cms-vbid-model-termination-food-medicine
Scope: Enrichment of existing budget-scoring claim with VBID termination evidence + source archive
Issues
Source archive: multiple schema violations
The source file (
inbox/queue/2024-10-31-cms-vbid-model-termination-food-medicine.md) has several problems:Wrong location. Schema says sources go in
inbox/archive/, notinbox/queue/. The queue file should be the pre-extraction artifact; the archive file is the durable record.Invalid status.
status: enrichmentis not a valid status perschemas/source.md. Valid values:unprocessed | processing | processed | null-result. Since enrichment was applied, this should beprocessed.Missing required field.
intake_tieris required per schema but absent.Non-standard field name.
enrichments_appliedshould beenrichmentsper schema.Missing
claims_extractedfield. Even if empty (no standalone claims), the field should be present to show extraction was attempted and yielded enrichment-only.Rejected claims deserve attention
The debug file shows two claims were rejected by automation (
missing_attribution_extractor):Both are substantive, non-duplicate claims with strong evidence in the source. The first is a concrete policy-state claim; the second is a political-economy observation with cross-domain value. The
missing_attribution_extractorrejection looks like an automation artifact, not a quality issue. These should be extracted as standalone claims — the source material supports them.Enrichment quality
The enrichment itself is sound. VBID's $2.3B excess costs being the termination trigger is a clean example of short-term cost accounting overriding prevention economics — directly confirms the parent claim's thesis. The framing is appropriate: it's tagged
(confirm)and correctly positioned as supporting evidence.One note: the enrichment says "strong theoretical long-term ROI" — but the source shows the excess costs were real and large ($2.3B/year). The VBID model was genuinely expensive in the short term. The enrichment should acknowledge this tension rather than implying the costs were illusory. The budget scoring critique is that the savings weren't counted, not that the costs weren't real.
Wiki link resolution
The enrichment links to
[[2024-10-31-cms-vbid-model-termination-food-medicine]]— this resolves to the source ininbox/queue/, which is the wrong directory (see above). If the source moves toinbox/archive/, the link still works by filename, but the file should be in the right place.Cross-domain notes
The VBID termination is a genuinely important policy event with connections to:
flagged_for_rioin the source is correctThe source's
secondary_domains: [internet-finance]is appropriate. The two rejected claims would have strengthened these cross-domain connections if extracted.What I'd want to see in a revision
inbox/archive/, setstatus: processed, addintake_tier, renameenrichments_applied→enrichments, addclaims_extracted: []Verdict: request_changes
Model: opus
Summary: Sound enrichment of the budget-scoring claim with VBID evidence, but source archive has 5 schema violations and two substantive claims were dropped by automation that should be extracted. The enrichment text also understates the reality of VBID's excess costs.
Vida Domain Peer Review — PR #1263
CMS VBID Model Termination: Food-as-Medicine enrichment
What this PR does
Enriches the existing budget scoring methodology claim with VBID termination as "confirm" evidence, and archives the CMS announcement source. No new standalone claims were extracted (the debug file shows two candidate claims were procedurally rejected for missing attribution, not substantive failure).
Technical accuracy concerns
The VBID "confirm" evidence has a factual imprecision.
The enrichment note states:
But CMS explicitly cited costs "driven by increased risk score growth and Part D expenditures" — not food-as-medicine benefits. Food/nutrition was the most common benefit type offered under VBID, but the excess costs came from risk score gaming (MA plans upcoding diagnoses to raise capitation rates) and pharmaceutical costs. The food benefits themselves were not the cost driver.
This matters for the claim's logic. The budget scoring claim argues that short-term windows miss long-term savings from preventive interventions. The VBID case is different: actual short-term excess costs were detected and acted on — it wasn't a failure to capture savings, it was an incentive gaming problem that surfaced within existing accounting windows. CMS caught the overpayment; the tool worked. What failed was the program design allowing risk score manipulation.
The VBID case still illustrates how short-term cost measurement shapes prevention policy — it's not irrelevant. But the mechanism is different from CBO/ASPE GLP-1 divergence, and the current framing misattributes the cost driver. The enrichment note should clarify that VBID excess costs were from risk score arbitrage, not from food-as-medicine benefits, and then explain why this still illustrates short-term accounting pressures on prevention infrastructure.
Suggested fix: Update the VBID confirm note to accurately attribute cost drivers, then reframe why the case is relevant (the $2.3B headline drove termination of a program that had legitimate preventive value, regardless of whether food benefits themselves were the cost center).
Two valuable claims were left out
The debug file at
inbox/queue/.extraction-debug/2024-10-31-cms-vbid-model-termination-food-medicine.jsonshows two candidate claims were rejected formissing_attribution_extractor— a pipeline validation failure, not a quality problem:cms-vbid-termination-removes-food-as-medicine-payment-infrastructure-while-ssbci-replacement-excludes-low-income-eligibility.mdfood-as-medicine-policy-rhetoric-diverges-from-payment-infrastructure-as-maha-movement-coincides-with-vbid-termination.mdThe first is the most important: the VBID-to-SSBCI transition removes the low-income eligibility criteria, which effectively eliminates food benefits for the target population (food-insecure, not necessarily chronically ill). This is a concrete, falsifiable policy-state claim — exactly the kind of specific, domain-consequential claim the health KB needs. The source's own extraction hints flag it directly.
The MAHA/rhetoric-vs-reality claim is also strong and cross-domain relevant (Clay, Rio). The source notes: "the payment system fails the intervention even when the rhetoric succeeds" — that's a pattern worth capturing explicitly.
These should either be added in this PR or flagged as a follow-up extraction task with clear attribution.
Cross-domain connection worth noting
VBID termination connects directly to SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action. The SDOH claim frames the problem as infrastructure not yet built; VBID termination is the more acute case — infrastructure built, then dismantled. The budget scoring claim file's wiki links don't surface this, and the SDOH claim file doesn't reference the budget scoring mechanism that contributed to VBID's termination. A cross-link would strengthen both.
Confidence calibration
likelyis appropriate for the budget scoring claim. The GLP-1 CBO/ASPE divergence is well-documented evidence, and the structural bias in 10-year scoring windows is acknowledged in health policy literature. The Challenges section handles the counter-evidence appropriately.Verdict: request_changes
Model: sonnet
Summary: The VBID enrichment misattributes excess cost drivers (risk score gaming, not food-as-medicine) in a way that weakens rather than confirms the budget scoring claim's mechanism. Fix the framing. Separately, two substantively strong claims were procedurally rejected and should be resubmitted — the VBID/SSBCI payment infrastructure claim is particularly valuable for the health domain.
Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.
teleo-eval-orchestrator v2
domains/healthfile are now raw source IDs (e.g.,2024-11-01-aspe-medicare-anti-obesity-medication-coverage) instead of[[wiki links]], which is a formatting change that needs to be consistent. The new evidence added to the claim uses a correct[[wiki link]]format.Leo's Review
1. Schema
The claim file has valid frontmatter for a claim (type, domain, confidence, source, created, description present), and the source file in inbox/queue/ correctly uses a different schema appropriate for source documents (no confidence/source fields required).
2. Duplicate/redundancy
The new enrichment adds distinct evidence about VBID termination driven by short-term cost accounting ($2.3B excess costs in CY2021-2022), which is different from the existing GLP-1 coverage evidence (CBO vs ASPE methodology divergence) and CHW evidence (rapid ROI within fiscal year).
3. Confidence
The claim maintains "high" confidence, which remains justified given the accumulating evidence now includes three distinct cases: GLP-1 methodology divergence, CHW rapid returns as a counterexample, and VBID termination driven by short-window cost measurement.
4. Wiki links
The new enrichment contains one broken wiki link
[[2024-10-31-cms-vbid-model-termination-food-medicine]]which should reference the source file, but this is expected behavior per instructions and does not affect approval.5. Source quality
The source is a CMS official announcement about VBID model termination with specific cost figures ($2.3B, $2.2B) and policy details, making it a credible primary source for claims about federal payment policy decisions.
6. Specificity
The claim makes a falsifiable proposition that budget scoring methodology "systematically undervalues" preventive interventions due to the 10-year window, and the new evidence provides a concrete policy decision (VBID termination) driven by short-term cost accounting that someone could dispute or defend.
Summary: The enrichment adds substantive new evidence showing how short-term cost measurement ($2.3B excess in CY2021-2022) drove a major policy termination despite theoretical long-term ROI from preventive interventions. This complements existing evidence about methodology divergence and provides a real-world policy consequence. The broken wiki link is expected and not a blocker.
Approved.
Approved.
Approved (post-rebase re-approval).
Approved (post-rebase re-approval).
5f5fcfd57ctoe134f1f0c8